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Purpose: The purpose of this study was to identify the mutation(s) or deletion(s) of the forkhead box protein L2
(FOXL2) gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
Methods: Genomic DNA extracted from peripheral blood was collected from two Chinese families and from one sporadic
case. PCR direct sequencing and quantitative real-time PCR-based copy number screening for the whole exon of
FOXL2 were performed.
Results: Direct sequencing revealed an indel mutation c.50C→TA in the sporadic case which resulted in a frameshift
generating 78 novel amino acids and terminating prematurely at codon 95. Deletions in the FOXL2 gene were confirmed
by quantitative real-time PCR (q-real-time PCR) in two families in which intragenic mutations were excluded by direct
sequencing. These changes containing deletions and a de novo mutation were not detected either in the non-carrier relatives
or in 100 normal controls.
Conclusions: This study identified two deletions and a de novo mutation in the FOXL2 gene in Chinese BPES patients.
This is the first study to report FOXL2 gene deletions detected by q-real-time PCR in this ethnic group. This technique
enriches the diagnostic methods of molecular genetics in BPES patients. The de novo mutation expands the mutation
spectrum of FOXL2.
Blepharophimosis-ptosis-epicanthus inversus syndrome
(BPES,  OMIM  110100)  is  a  rare  genetic  disorder
characterized  by  eyelid  malformation  and  ovarian
dysfunction. Based on the presence or absence of premature
ovarian  failure  (POF),  two  clinical  types  have  been
distinguished:  type  I  is  associated  with  POF  in  affected
females, whereas type II is not [1]. BPES is primarily inherited
in  an  autosomal  dominant  manner,  but  may  also  occur
sporadically, although the autosomal recessive pattern has
also  been  reported  in  one  consanguineous  family  [2].
According  to  cytogenetic  rearrangements  [3]  and  linkage
analyses  [4-6],  BPES  had  been  mapped  to  the  human
chromosome  3q23  region.  Subsequently,  the  FOXL2
(forkhead box protein L2, OMIM 605597) gene was identified
as  the  pathogenic  gene  for  BPES  [7].  Furthermore,  non-
syndrome POF and granular cell tumors of the ovary may be
associated with FOXL2 mutations [8,9].
Correspondence to: Dr. Yanhua Qi, Department of Ophthalmology,
the 2nd Affiliated Hospital of Harbin Medical University, 246 Xuefu
Road,  Harbin,  Heilongjiang,  150086,  China;  Phone:
86-451-86605851;  FAX:  86-451-86605116;  email:
qi_yanhua@yahoo.com
The FOXL2 protein comprising 376 amino acids is a
member  of  the  large  family  of  winged-helix/forkhead
transcription factors that play important roles in a variety of
developmental processes [10]. FOXL2 contains an unique
DNA-binding  domain  of  100  residues  with  amino  acid
positions from 52 to 152, and a polyalanine tract of 14 residues
with amino acid positions from 221 to 234 (Figure 1). A
comparative analysis shows that the entire open reading frame
(ORF) of FOXL2 is highly conserved in several vertebrate
species [11]. Expression studies have shown that the FOXL2
protein is expressed in the mesenchyme of developing mouse
eyelids and in fetal and adult ovarian granulosa cells, which
is consistent with the preconceived role of FOXL2 in early
eyelid development and ovarian maintenance [7].
To date, more than 125 mutations have been reported in
individuals with BPES type I and II. Among all genetic defects
found  in  BPES,  an  estimated  72%  of  cases  are  due  to
intragenic  FOXL2  mutations  [12];  2%  of  cases  involve
cytogenetic  rearrangements  containing  unbalanced
translocations and interstitial deletions of 3q23 [13]; about
12% of BPES cases result from deletions involving partial or
whole FOXL2 gene deletion and contiguous gene deletion,
including FOXL2 and adjacent gene(s) [13]; and about 5% of
cases involve regulatory deletions outside the FOXL2 gene
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436[14]. Using multiplex ligation-dependent probe amplification
(MPLA)  and  quantitative  PCR  [15],  deletions  leading  to
FOXL2 haploinsufficiency may be detected in individuals
with  typical  BPES  in  which  intragenic  mutations  were
excluded by sequencing of the FOXL2 ORF.
The purpose of this study was to identify the mutation(s)
or deletion(s) of FOXL2 in two Chinese families and one
sporadic case with BPES, using the technique of PCR direct
sequencing  and  quantitative  real-time  PCR  (q-real-time
PCR).  This  is  the  first  report  deletion  detection  in  the
FOXL2 region using q-real-time PCR in a Chinese ethnic
population.
METHODS
Patients: Five BPES patients and four of their relatives were
recruited  from  Heilongjiang  province  in  the  northeast  of
China,  as  well  as  two  unrelated  families  (F1,  F2)  and  a
sporadic case (S1). Informed consent was obtained from their
parents or guardians. One hundred healthy normal controls
were  also  involved  in  this  study.  The  study  protocol
conformed to the ethical guidelines of the 1975 Declaration
of  Helsinki  and  was  approved  by  the  Heilongjiang
Institutional Review Board (Harbin, China).
Clinical information about the patients was obtained from
an ophthalmologist, an endocrinologist, and a gynecologist
using the standardized diagnostic criteria. Where possible,
facial photographs were obtained with patient approval.
Mutation detection: Blood samples from BPES patients and
their healthy relatives were collected and stored at −20 °C.
Genomic  DNA  was  extracted  from  peripheral  blood
leucocytes using a QIAamp DNA Mini kit (Qiagen, Hilden,
Germany).
The whole exon of the FOXL2 gene containing coding
and flanking regions was amplified by the polymerase chain
reaction (PCR) method using the primers listed in Table 1.
The PCR reaction mixture (50 µl) contained 12.5 µl 2× GC
Buffer II, 200 µmol/l dNTP mix, 1 unit of LA Taq polymerase
(TakaRa Biotechnology Co. Ltd., Dalian, China), 10 pmol
primer  pairs  and  100  ng  genomic  DNA.  PCR  cycling
conditions were as follows: pre-degeneration at 95 °C for 3
min, then 38 cycles of denaturation, annealing and extension,
followed by a final extension at 72 °C for 10 min. The PCR
products were directly sequenced on an automated sequencer
(ABI 3730XL Genetic Analyzer; Applied Biosystems, Foster
City, CA) to perform mutation analysis.
Figure 1. Diagram of the FOXL2 gene and positions of the amplification segments by the q-real-time PCR primers in FOXL2. Shaded areas
represent the DNA-binding domain and the polyalanine tract in the coding region of FOXL2, respectively. Black boxes indicate the location
of the amplification segments of two pairs of primers with respect to the nucleotide (top) numbering.
TABLE 1. LIST OF THE PRIMERS AND ANNEALING TEMPERATURES USED FOR THE AMPLIFICATION OF THE WHOLE EXON OF THE FOXL2
GENE CONTAINING CODING AND FLANKING REGIONS WITH BPES.
Primer Sequence (5′-3′) Product length
(bp)
Annealing temperature (°C)
AF GTGGAGCCCATACGAATCAG 610 62
AR GTACGAGTACGGGGGCTTCT    
BF CAGCGCCTGGAGCGGAGAG 545 64
BR CTTGCCGGGCTGGAAGTGC    
CF GACCCGGCCTGCGAAGACA 517 66
CR GGCCGCGTGCAGATGGTGT    
DF CGCGGCCGCTGTGGTCAAG 500 68
DR GCTGGCGGCGGCGTCGTC    
EF CCTCTTTGTCCCCTCAGTTTA 467 51
ER CGGTGTAAACCGAGTACAGG    
FF AGAAAGGGACGGACCAATAC 518 55
FR CAGATAGGGAGAGGGTGAAAC    
GF GAAGTATTGTGGCCTTGGAGT 542 55
GR ATTTATTCGGGAATCGACAAG    
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437Quantitative real-time PCR analysis: The real-time primers,
as listed in Table 2, were designed and provided by TakaRa
(TakaRa  Biotechnology  Co.  Ltd.).  The  amplification
segments of the two pairs of primers were located in the 5′ and
3′  ends  of  the  FOXL2  gene,  respectively  (Figure  1).  The
gDNA was used as template in q-real-time PCR reactions with
SYBR® Green PCR Master Mix (TakaRa Biotechnology Co.
Ltd.)  and  performed  using  a  7000  real-time  PCR  system
(Applied  Biosystems).  The  quantification  of  the  target
sequences was normalized to an assay of chromosome 21, C2,
and the relative copy number (RCN) was determined on the
basis of the comparative ΔΔcycle threshold (Ct) method with
a normal control DNA as the calibration standard [16]. The
experiments were repeated three times. A ≈0.5-fold change in
RCN was used as the benchmark for deletion.
RESULTS
Clinical  findings:  All  three  probands  indicated  typical
features of BPES, including small palpebral fissure, ptosis of
the eyelids, epicanthus inversus, and telecanthus. In addition
to  eyelid  malformations,  other  eye  abnormalities  were
detected in some of these patients. In family 1 (Figure 2A),
the proband (F1-III:4) was diagnosed with bilateral amblyopia
and strabismus. His mother (F1-II:6), who had undergone
eyelid surgeries in childhood, did not suffer from POF at the
time of this study, and was diagnosed BPES type II. In family
2 (Figure 2B), the BPES type of the female child (F2-III:1)
could not be determined. Her father (F2-II:1) was a 27-year-
old BPES patient who presented some abnormalities such as
bilateral  amblyopia,  strabismus,  and  ophthalmoplegia,
besides  ocular  abnormalities  characteristic  of  BPES.  In
addition to the typical ocular manifestations of BPES, the 3-
year-old  girl  in  the  sporadic  case  (S1)  had  no  other
developmental  abnormalities.  Neither  of  her  parents  had
clinical evidence of this disorder. Clinical data for the patients
in this study are summarized in Table 3.
Mutations in FOXL2: In the sporadic case (S1), bidirectional
sequencing of the whole exon of FOXL2 revealed an indel
mutation, C→TA at nucleotide 50 (c.50 delCinsTA, Figure
3A).  This  was  a  frameshift  mutation  expected  to  cause
TABLE 2. LIST OF Q-REAL-TIME PCR PRIMERS.
    Position in chromosome 3*
Primer Sequence (5′→3′) Start End
foxl2–1F CATCGCGAAGTTCCCGTTCTA 140147983 140148003
foxl2–1R CACCTTGATGAAGCACTCGTTGA 140147910 140147932
foxl2–2F GCTATCAGTCCCGTCGCTTC 140146430 140146449
foxl2–2R TTAGCAAACTCCAAGGCCACA 140146289 140146309
C2-F CAATTCAGGTCAGGTGATAACTCAGTAA - -
C2-R GCCAGGTTTAGAATGTTTGTCTAAGTC - -
          *The position of the primers are given with respect to the Human Genome Browser Gateway.
Figure  2.  Eyelid  photographs  and
pedigrees of BPES patients from two
families. A: Pedigree of family 1 (F1)
and  picture  of  eyelid  feature  of  the
proband. B: Pedigree and photographs
of eyelid feature observe of the proband
and  father  in  family  2  (F2).  Squares
circles  indicate  males  and  females,
respectively,  and  the  black  symbols
represent  patients.  Asterisks  indicate
analyzed  individuals.  The  arrows
indicate the proband.
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438miscoding of 78 amino acids from codon 17, and eventually
a premature stop codon at codon 95. This change was not
detected in either of proband’s parents or in the 100 normal
controls (Figure 3B).
Quantitative  real-time  PCR  analysis:  Since  intragenic
mutations were excluded by direct sequencing of FOXL2 in
the two BPSE families, we then considered whether FOXL2
gene deletion existed in the patients. This was subsequently
confirmed by the q-real-time PCR technique. The study found
that the relative copy numbers (RCNs) of the patients were
about half that of the healthy individuals (Figure 4). Copy
number  variations  (CNVs)  measured  by  q-real-time  PCR
signified that the deletion of FOXL2 led to haploinsufficiency.
To confirm the CNVs found in the present study, the q-real-
time PCRs were performed at least three times to eliminate
handling error. As expected, no deletion was detected either
in non-carrier relatives or in BPES-free controls.
DISCUSSION
In  two  families  (F1,  F2)  with  BPES,  two  deletions  in
FOXL2  were  detected  and  characterized  by  an  efficient
technique using q-real-time PCR. Compared to fluorescent in
situ hybridization (FISH) and multiplex ligation-dependent
probe  amplification  (MLPA)  analysis,  q-real-time  PCR
appeared to be more convenient [15]. In the present study, the
copy numbers of the amplification segments located at the 5′
and 3′ ends of FOXL2 were approximately 50% that of healthy
individuals  (Figure  4),  which  suggested  that  FOXL2  was
deleted  in  the  region  encompassing  these  amplification
segments. Since FOXL2 deletions are found in at least 12%
of BPSE cases [13], deletion screening is now routinely used
for molecular diagnosis of BPES. Based on the predictions of
Beysen et al. [14], deletions encompassing FOXL2 have no
reliable genotype-phenotype correlations with regard to POF.
However,  according  to  a  study  by  D’haene  et  al.  [15],
FOXL2 deletions may be associated with varying degrees of
ovarian dysfunction. Therefore, we attempted to assess the
BPES type in the two families. In family 1, the absence of
female  infertility  or  POF  in  II:6  suggested  that  this  gene
deletion did not affect the ovarian expression of FOXL2, and
thus led to BPES type II. However, in family 2, the BPES type
could  not  be  determined  owing  to  the  prepubertal
developmental stage of the female child. FOXL2 deletions
causing haploinsufficiency of this gene may affect ovarian
function, leading to POF with a variable age of onset [15].
Therefore, apart from the ophthalmological follow-up, young
TABLE 3. THE CLINICAL FINDINGS OF PATIENTS IN THIS STUDY.
Individual Type of BPES Clinical data
F1* II:6 II 32-year-old female with refractive error and normal levels of sex hormones.
  III:4   7-year-old boy with bilateral amblyopia and strabismus, no clinical data about mental retardation.
F2* II:1 Undetermined 27-year-old male with bilateral amblyopia and strabismus and ophthalmoplegia.
  III:1   1-year-old girl with the normal growth development and the undetermined BPES type.
S* S1 II 3-year-old girl with the risk of having POF, no clinical data about other abnormal development.
           *F1=family 1; F2=family 2; S=sporadic case.
Figure  3.  Mutation  analysis  from
sporadic case (S1). A: Partial nucleotide
sequences of FOXL2 from patient. The
sequence showed an indel mutation, c.
50delCinsTA (indicated by the arrow).
This  de  novo  mutation  resulted  in  a
frameshift mutation expected to cause
miscoding  of  78  amino  acids  from
codon 17 and eventually a premature
stop codon at 95. B: The parents and the
control subjects lacked this change.
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439female patients of undetermined phenotype require a close
endocrinological and gynecological follow-up. Importantly,
this study is the first to report a FOXL2 gene deletion in a
Chinese ethnic population detected by quantitative real-time
PCR. Consequently, we have identified q-real-time PCR as a
relatively  reliable,  convenient  and  inexpensive  molecular
diagnostic tool for deletion screening of FOXL2, which will
facilitate  genetic  counseling  for  BPES  patients  and  help
identify  those  female  patients  who  require  an  extended
clinical follow-up for POF.
BPES features typically include epicanthus inversus (fold
curving in the mediolateral direction, inferior to the inner
canthus), low nasal bridge, and ptosis of the eyelids leading
to both vertical and horizontal narrowing of the palpebral
fissures. Thus, subjects with BPES have smaller than normal
eyelid openings. The ptosis is usually bilateral and symmetric.
Additional dysmorphic features of the eye include nystagmus,
microphthalmos,  microcornea,  and  stenosis  of  the  lateral
canaliculi [17]. The F1 and F2 families shared similar features
to those described above that characterize BPES, including
ptosis of the eyelids, epicanthus inversus and telecanthus.
Other ocular abnormalities in the F1 and F2 families included
bilateral amblyopia, strabismus, and ophthalmoplegia, which
may not be common features of BPES. Apart from the eye
abnormalities, patients carrying deletions in FOXL2 presented
more frequently associated clinical findings. D'haene et al.
[15] commented that psychomotor retardation was noted in
some patients with a haploinsufficiency of the FOXL2 gene.
Microcephaly was reported in some cases with large deletions
of FOXL2 involving the neighboring ataxia telangiectasia and
Rad3 related (ATR) gene [18]. As reported here, however, III:
4 in F1 carrying a deletion in the FOXL2 region presented
normal psychomotor and mental developments at age 7 years,
which  suggested  that  there  was  not  an  exact  genotype-
phenotype correlations attributed to deletions of the FOXL2
region. Owing to the infancy of III:1 in F2, associated clinical
findings such as psychomotor delay and microcephaly could
not  be  determined.  Therefore,  it  may  be  important  for
providing a prognosis regarding associated clinical findings
in new borns with BPES carrying a FOXL2 deletion.
In a 3-year-old girl with sporadic BPES (S1), we found a
de novo mutation which had a C deletion associated with a
TA dinucleotide insert at position 50, resulting in a frameshift
generating 78 novel amino acids and terminating prematurely
at codon 95. The mutation led to a truncated protein in which
the entire forkhead DNA-binding domain was erased; this was
not found in her parents who lacked clinical evidence of the
disorder. Predictions from De Baere et al. [19] suggested that
intragenic mutations that resulted in proteins truncated before
the polyalanine tract probably led to BPES type I. Therefore,
the  female  child  will  need  regular  evaluation  by  an
endocrinologist or gynecologist to explore the possibility of
sterility or to anticipate POF [20].
The deletions of FOXL2 reported in this study which
caused the haploinsufficiency leading to the presence of a null
allele may result in a disable transcript undergoing nonsense-
mediated decay [21] as a causative mechanism for BPES. It
has been reported that the truncated protein formed as a result
of intragenic mutations is strongly aggregated in the nucleus
[11]. Aggregation of the protein seriously impairs its DNA-
binding function, and then influences interactions with the
other proteins. Since the entire polyalanine tract of the COOH-
terminus of FOXL2 is important for transcriptional repression
of the steroidogenic acute regulatory (StAR) gene [22], either
the FOXL2 deletion or mutation-dependent protein truncation
before the polyalanine tract might increase StAR expression,
thereby resulting in the development of POF. The clinical
findings and genetic analysis in the sporadic case, together
with findings that intragenic mutations can seriously impair
the function of the FOXL2 protein [11] suggest that a single
mutation in FOXL2 can cause complete inactivation of the
gene product. As a result, the genetic mutation in the sporadic
case can, in effect, produce the same disruption in FOXL2
Figure 4. Quantitative real-time PCR analysis from two families. Deletions of CNVs in FOXL2 are shown in BPES patients from family 1
(A) and family 2 (B), respectively. The histogram of amplification products of the two pairs of q-real-time PCR primers indicate that the mean
gene copy number in samples from BPES-affected family members was half that of samples from unaffected family members.
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440gene function as gene deletions, leading to development of the
BPES and POF phenotypes.
In  conclusion,  this  study  provides  the  first  report  of
FOXL2 gene deletions in a Chinese ethnic population detected
by quantitative real-time PCR. It supports the application of
quantitative real-time PCR techniques as a relatively reliable,
convenient and inexpensive method for detecting genetics
abnormalities  in  BPES  patients.  Meanwhile,  the  de  novo
mutation in the sporadic case broadens the mutation spectrum
of FOXL2. The new information concerning mutations in
FOXL2 and the more widespread use of q-real-time PCR for
deletion screening is likely to facilitate the clinical genetic
diagnosis of BPES and lead to improved genetic counseling
for a larger number of BPES patients.
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